Revolution Medicines Inc (RVMD)
56.05
+0.18
(+0.32%)
USD |
NASDAQ |
Nov 05, 14:45
Revolution Medicines Enterprise Value: 7.742B for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 7.742B |
| November 01, 2024 | 7.611B |
| October 31, 2024 | 7.346B |
| October 30, 2024 | 6.845B |
| October 29, 2024 | 6.831B |
| October 28, 2024 | 6.385B |
| October 25, 2024 | 6.163B |
| October 24, 2024 | 6.302B |
| October 23, 2024 | 6.512B |
| October 22, 2024 | 6.282B |
| October 21, 2024 | 6.385B |
| October 18, 2024 | 6.833B |
| October 17, 2024 | 6.761B |
| October 16, 2024 | 6.831B |
| October 15, 2024 | 6.593B |
| October 14, 2024 | 6.631B |
| October 11, 2024 | 6.841B |
| October 10, 2024 | 6.678B |
| October 09, 2024 | 6.676B |
| October 08, 2024 | 6.723B |
| October 07, 2024 | 6.317B |
| October 04, 2024 | 6.314B |
| October 03, 2024 | 6.115B |
| October 02, 2024 | 6.090B |
| October 01, 2024 | 5.954B |
| Date | Value |
|---|---|
| September 30, 2024 | 5.984B |
| September 27, 2024 | 5.787B |
| September 26, 2024 | 5.736B |
| September 25, 2024 | 5.903B |
| September 24, 2024 | 5.826B |
| September 23, 2024 | 5.530B |
| September 20, 2024 | 5.996B |
| September 19, 2024 | 6.123B |
| September 18, 2024 | 5.769B |
| September 17, 2024 | 5.721B |
| September 16, 2024 | 5.849B |
| September 13, 2024 | 5.709B |
| September 12, 2024 | 5.420B |
| September 11, 2024 | 5.368B |
| September 10, 2024 | 5.363B |
| September 09, 2024 | 5.445B |
| September 06, 2024 | 5.398B |
| September 05, 2024 | 5.632B |
| September 04, 2024 | 5.493B |
| September 03, 2024 | 5.351B |
| August 30, 2024 | 5.530B |
| August 29, 2024 | 5.392B |
| August 28, 2024 | 5.533B |
| August 27, 2024 | 5.691B |
| August 26, 2024 | 5.769B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
560.77M
Minimum
May 12 2022
7.742B
Maximum
Nov 04 2024
2.236B
Average
1.734B
Median
Jun 26 2023
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 530.78M |
| Electromed Inc | 180.63M |
| Xtant Medical Holdings Inc | 101.94M |
| Myomo Inc | 106.78M |
| Catheter Precision Inc | 2.064M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -133.23M |
| Total Expenses (Quarterly) | 156.64M |
| EPS Diluted (Quarterly) | -0.81 |
| Earnings Yield | -6.62% |
| Normalized Earnings Yield | -6.851 |